Your Guide to Navigating Sublocade Medication Management Support

Your Guide to Navigating Sublocade Medication Management Support

Understanding long acting injectables

When you explore medication-assisted treatment, long acting injectables offer a reliable option for managing opioid use disorder or preventing relapse. Sublocade and Vivitrol deliver monthly doses that reduce cravings and withdrawal symptoms, creating a steady foundation for recovery. With tailored treatment programs and comprehensive care, you gain the support necessary for lasting recovery.

What is Sublocade

Sublocade is a long-acting injectable form of buprenorphine designed for adults with moderate to severe opioid use disorder. Administered once a month under the skin of the abdomen, Sublocade creates a depot that gradually releases medication over 30 days, helping you avoid daily dosing fluctuations. Key features include:

  • Controlled buprenorphine delivery to reduce cravings and withdrawal symptoms
  • A same-day start option, even if you have not taken buprenorphine before [1]
  • Rapid build-up phase with two initial injections (300 mg) followed by monthly maintenance doses (100 mg) [2]
  • Proven benefit: 28 percent treatment success with Sublocade plus counseling versus 2 percent on placebo plus counseling in clinical trials [1]
  • Over 350,000 patients prescribed through February 2025 [1]

What is Vivitrol

Vivitrol is an extended-release injectable naltrexone indicated for alcohol relapse prevention and opioid relapse prevention following detoxification. Administered monthly into the buttock or upper arm, Vivitrol blocks opioid receptors to curb cravings and the effects of any opioid taken. Highlights include:

  • Monthly naltrexone injection after a confirmed opioid-free period
  • Suitable for both alcohol use disorder and opioid relapse prevention [2]
  • No abuse potential—naltrexone is an opioid antagonist
  • Complementary psychosocial support enhances outcomes

Comparing Sublocade and Vivitrol

Feature Sublocade Vivitrol
Active ingredient Buprenorphine (partial agonist) Naltrexone (antagonist)
Induction requirement Test dose of transmucosal buprenorphine Complete detoxification from opioids
Mechanism Gradual release depot to reduce cravings Blocks opioid receptors to prevent effects
Administration frequency Once monthly Once monthly
Start option Same-day start, even without prior buprenorphine After 7–10 days opioid-free
Risk of misuse Low, supervised injection None, antagonist
Counseling requirement Part of a complete treatment plan Part of relapse prevention services

Insurance coverage for injectable medication-assisted treatment varies by plan and state. Understanding your benefits helps you access programs with minimal out-of-pocket expense.

Verifying benefits and eligibility

To confirm your coverage for monthly injectables:

  • Contact your insurer’s pharmacy or MAT benefits department
  • Ask about prior authorization requirements and step therapy
  • Check Medicaid or Medicare coverage: many state programs cover Sublocade injections [3]
  • Use our insurance verified injectable MAT program for step-by-step assistance
  • Explore manufacturer co-pay assistance or patient support programs

Coverage for Sublocade

Many private insurers and government plans cover Sublocade as part of medication-assisted treatment. You can streamline access via:

Coverage for Vivitrol

Coverage for Vivitrol injections typically requires documentation of medical necessity and proof of detoxification. Support options include:

Preparing for monthly injections

Proper preparation ensures each appointment goes smoothly and maximizes treatment benefits.

Initial induction and test dosing

For Sublocade:

  1. Complete a test dose of transmucosal buprenorphine to confirm tolerability
  2. Schedule your first injection—same-day starts are available even without prior buprenorphine use [1]
  3. Receive the second shot within one week to one month to build medication levels rapidly

For Vivitrol:

  • Complete medically supervised detox to ensure a minimal 7- to 10-day opioid-free period
  • Arrange your first injection and follow up monthly

Use our telehealth sublocade appointment setup or vivitrol treatment with telehealth follow up options to reduce travel and maintain continuity of care.

Monitoring and lab work

Regular follow-up visits include:

  • Injection site inspection
  • Vital signs and mental health assessments
  • Periodic liver function tests and blood work

These measures ensure your safety and help adjust dosing if needed.

Managing side effects

Common side effects may include injection site reactions, constipation, sleep disturbances, or nausea. Serious but rare risks involve respiratory depression or severe allergic reaction [5]. To manage side effects:

  • Report any unusual symptoms promptly
  • Stay hydrated and maintain fiber intake to ease constipation
  • Work with your provider for dose adjustments or supportive medications

Integrating counseling and support

No injectable treatment stands alone. Combining medications with psychosocial interventions boosts your chances of lasting recovery.

Counseling integration

Clinical data show 28 percent of patients on Sublocade plus counseling achieved treatment success versus 2 percent on placebo plus counseling [1]. To integrate support:

Building a supportive environment

You benefit from:

  • Peer support groups and sober living networks
  • Family education and involvement
  • 24/7 helplines and crisis management
  • Telehealth check-ins to maintain accountability

Tips for long term success

Consistency and a proactive approach help you sustain progress:

  1. Keep all injection appointments and follow-up visits
  2. Adhere to counseling schedules and homework assignments
  3. Monitor mood and cravings with journaling or mobile apps
  4. Develop healthy routines—sleep, nutrition, exercise
  5. Surround yourself with a supportive community
  6. Update your treatment plan as your needs evolve

Finding a treatment provider

Locating the right clinic or specialist is key to a seamless experience.

Local clinics and telehealth options

Questions to ask potential providers

  • What is your experience with monthly injectables?
  • How do you handle side effect monitoring and emergencies?
  • Can you assist with insurance authorization and billing?
  • Do you offer integrated counseling or referrals?
  • Are telehealth visits available between injections?

By understanding your options for Sublocade and Vivitrol, verifying coverage, preparing for injections, and engaging in counseling, you can build a comprehensive, individualized plan that supports lasting recovery. Reach out today to start your journey with expert guidance and compassionate care.

References

  1. (Sublocade)
  2. (American Addiction Centers)
  3. (sublocade appointment covered by medicaid)
  4. (SAMHSA)
  5. (Healthline)

Start Your Healing Journey with Carolina Energetics PC

Ready to begin your path to recovery? Contact us now to schedule a consultation and experience the difference of personalized, professional care in a welcoming environment.

Office Hours
Blood Testing Hours
Urine Testing Hours

Save Buprenorphine

Buprenorphine is under threat—and so are the patients who depend on it.

This life-saving medication is now listed as a “suspicious drug,” leading many pharmacies to stop dispensing it altogether. The DEA is pushing for everyone to switch to Buprenorphine/Naloxone (Suboxone), but not every patient can tolerate Naloxone. Many experience severe side effects or have legitimate sensitivity—even when allergy tests fail to detect it.

We’ve seen firsthand the damage this policy shift is causing.

We need your voice. Congressmen Paul Tonko and Senator Martin Heinrich are sponsoring a bill to protect access to Buprenorphine, and bipartisan support is growing. We urge you to contact your state Senators and President Trump online to support this bill. Your advocacy could help restore patient choice and save lives.

Don’t let politics get in the way of proper care. Help us protect access to Buprenorphine.